qRT-PCR and immunoblotting analysis examined the effect of PRMT6 on CDC20 expression, and found that depletion of PRMT6 inhibited the mRNA and protein levels of CDC20, whereas PRMT6 overexpression promoted the expression of CDC20 in GBM cells (Fig. 4D, E). The gene discussed is CDC20; the disease is glioblastoma.